Bayesian continual reassessment method for dose-finding trials infusing T cells with limited sample size.
about
Developing a Bayesian adaptive design for a phase I clinical trial: a case study for a novel HIV treatment.Should clinical trials be approached differently for rare cancers?Overall success rate of a safe and efficacious drug: Results using six phase 1 designs, each followed by standard phase 2 and 3 designs
P2860
Bayesian continual reassessment method for dose-finding trials infusing T cells with limited sample size.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Bayesian continual reassessmen ...... ells with limited sample size.
@ast
Bayesian continual reassessmen ...... ells with limited sample size.
@en
type
label
Bayesian continual reassessmen ...... ells with limited sample size.
@ast
Bayesian continual reassessmen ...... ells with limited sample size.
@en
prefLabel
Bayesian continual reassessmen ...... ells with limited sample size.
@ast
Bayesian continual reassessmen ...... ells with limited sample size.
@en
P2093
P2860
P1476
Bayesian continual reassessmen ...... ells with limited sample size.
@en
P2093
Donald Berry
Elizabeth J Shpall
Laurence J N Cooper
Partow Kebriaei
Richard Champlin
P2860
P304
P356
10.1080/10543406.2011.582972
P577
2012-01-01T00:00:00Z